Literature DB >> 18776315

Inhibition of human papillomavirus replication by using artificial zinc-finger nucleases.

Takashi Mino1, Tomoaki Mori, Yasuhiro Aoyama, Takashi Sera.   

Abstract

Recently, we have designed artificial zinc-finger proteins (AZPs) that prevent a viral replication protein, E2, of human papillomavirus type 18 (HPV-18) from binding to its replication origin and demonstrated that the gene-delivered AZPs inhibited HPV-18 DNA replication in mammalian cells. In the present study, we examined a new approach to inhibition of DNA virus replication by using an AZP-nuclease fusion. In transient replication assays for HPV-18, the gene-delivered AZP-nuclease fusion reduced the viral DNA replication rate significantly. Moreover, it was demonstrated by ligation-mediated PCR that viral DNA regions close to the AZP-binding site were cleaved in the cells by the AZP-nuclease. Thus, our results demonstrate that AZP-nucleases have potentials to inhibit replication of any DNA viruses whose replication mechanisms remain unsolved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776315     DOI: 10.1093/nass/nrn094

Source DB:  PubMed          Journal:  Nucleic Acids Symp Ser (Oxf)        ISSN: 0261-3166


  3 in total

Review 1.  Rationalizing the development of live attenuated virus vaccines.

Authors:  Adam S Lauring; Jeremy O Jones; Raul Andino
Journal:  Nat Biotechnol       Date:  2010-06-07       Impact factor: 54.908

2.  Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis.

Authors:  Kai-Erik Uleberg; Irene Tveiterås Ovestad; Ane Cecilie Munk; Cato Brede; Bianca van Diermen; Einar Gudlaugsson; Emiel A M Janssen; Anne Hjelle; Jan P A Baak
Journal:  Int J Proteomics       Date:  2014-06-15

3.  Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design.

Authors:  Sumitra Shankar; Ahalya Sreekumar; Deepti Prasad; Ani V Das; M Radhakrishna Pillai
Journal:  Cancer Cell Int       Date:  2018-10-22       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.